Hofseth Biocare ASA (HOFBF) Stock Statistics & Valuation Metrics

Hofseth Biocare ASA has a market cap or net worth of $60.20M. The enterprise value is $944.88M.

Hofseth Biocare ASA has 395,081,020 shares outstanding. The number of shares has decreased by -2.65% in one year.

Hofseth Biocare ASA’s return on equity (ROE) is 1.80 and return on invested capital (ROIC) is -50.03%.

The current PE Ratio of Hofseth Biocare ASA is ―. Hofseth Biocare ASA’s PEG ratio is ―.

In the last 12 months, Hofseth Biocare ASA had revenue of 254.43M and earned -134.88M in profits. Earnings per share was -0.33.

In the last 12 months, operating cash flow was -28.37M and capital expenditures -25.81M, giving a free cash flow of -54.18M billion.

Hofseth Biocare ASA pays an annual dividend of ―, resulting in a dividend yield of ―

Hofseth Biocare ASA upcoming earnings date is May 8, 2026, TBA (Confirmed).

Hofseth Biocare ASA as a current ratio of 0.67, with Debt / Equity ratio of -401.87%

In the past 12 months, Hofseth Biocare ASA has paid 176.00K in taxes.

Hofseth Biocare ASA EV to EBITDA ratio is -10.60, with an EV/FCF ratio of -12.18.

Hofseth Biocare ASA has $67.05M in cash and marketable securities with $236.19M in debt, giving a net cash position of -$233.73M billion.

Gross margin is 18.79%, with operating margin of -44.29%, and net profit margin of -53.01%.

The average price target for Hofseth Biocare ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―